Mar-Afatinib 40 mg

Afatinib 40 mg tablets are a targeted therapy option for specific cancer treatments. This oral medication is designed to inhibit certain proteins that may contribute to cancer growth.

Afatinib 40 mg tablets are primarily used in the treatment of non-small cell lung cancer (NSCLC) and other advanced cancers. This medication works by targeting specific proteins that can drive cancer cell growth. Patients often wonder, 'What is Afatinib used for?' It is typically prescribed for conditions where these proteins are overactive.

Common effects of Afatinib 40 mg tablets may include skin rash, diarrhea, and fatigue. Some users may also experience nausea or loss of appetite. These effects can vary widely among individuals.

Afatinib 40 mg tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding administration and monitoring. Patients should be aware of potential side effects and report any severe reactions promptly.

Afatinib 40 mg tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.